| --- | --- | |--------------------------------------|-------| | | | | | | | | | | | | | Fiscal 2024 | | | Third Quarter | | | Earnings Call | | | David Mutryn Chief Financial Officer | | | August 8, 2024 | | Forward-looking Statements & Non-GAAP Information These slides should be read in conjunction with our most recent quarterly earnings press release, along with listening to or reading a transcript of management comments from our most recent quarterly earnings conference call. This document may contain n ...

For the quarter ended June 2024, Maximus (MMS) reported revenue of $1.31 billion, up 10.6% over the same period last year. EPS came in at $1.74, compared to $0.78 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.28 billion, representing a surprise of +3.02%. The company delivered an EPS surprise of +18.37%, with the consensus EPS estimate being $1.47. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...

Maximus (MMS) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 18.37%. A quarter ago, it was expected that this government health services provider would post earnings of $1.31 per share when it actually produced earnings of $1.57, delivering a surprise of 19.85%. Over the last four qu ...

Wall Street analysts forecast that Maximus (MMS) will report quarterly earnings of $1.47 per share in its upcoming release, pointing to a year-over-year increase of 88.5%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 7.4% compared to the year-ago quarter. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ...

Maximus, Inc. (MMS) shares have had an impressive run in the past three months. The stock has rallied 11% compared with the 7% growth of its industry and the 8.8% increase of the Zacks S&P 500 composite. This rally aligns with the performance of its closest competitors, Booz Allen Hamilton (BAH) , which has risen 7%, and Accenture (ACN) , which has rallied 4% over the same period. Zacks Investment Research Image Source: 3 Months Price Performance The stock closed at $89.98 in its last trading session, close ...

Group 1 - The core investment strategy discussed is value investing, which focuses on identifying companies that are undervalued by the market [1] - Maximus (MMS) is highlighted as a strong value stock, currently holding a Zacks Rank of 1 (Strong Buy) and an A grade for Value [6] - The P/S ratio for MMS is 1.04, which is lower than the industry average of 1.36, indicating potential undervaluation [3][4] Group 2 - MMS has a P/E ratio of 14.33, significantly lower than the industry's average of 21.25, suggesting it may be undervalued [6] - The stock's Forward P/E has fluctuated between 13.66 and 19.09 over the past 12 months, with a median of 15.09 [6] - MMS's P/CF ratio is 13.96, compared to the industry's average of 21.77, further indicating its attractive valuation [7]

Core Viewpoint - Maximus reported strong second-quarter fiscal 2024 results, with earnings and revenues exceeding expectations, indicating positive momentum leading into future earnings releases [2][10]. Financial Performance - Adjusted earnings for Q2 were $1.57 per share, surpassing the Zacks Consensus Estimate by 19.9% and increasing 96.3% year-over-year [2]. - Revenues reached $1.35 billion, beating the consensus mark by 5.4% and rising 11.7% from the previous year [2]. Segmental Revenues - U.S. Services segment revenues were $486.1 million, an 8.1% year-over-year increase, exceeding estimates [3]. - U.S. Federal Services segment revenues were $701.7 million, a 20.1% increase from the prior year, also beating estimates [3]. - Outside the U.S. segment revenues were $160.5 million, a 7.2% decrease year-over-year, missing estimates [3]. Sales and Pipeline - Year-to-date signed contract awards totaled $568 million, with pending contracts amounting to $797 million [4]. - The sales pipeline was valued at $37.8 billion, including $1.3 billion in pending proposals and $35.5 billion in tracking opportunities [4]. - The book-to-bill ratio was 1.1X as of March 31, 2023 [4]. Operating Performance - Adjusted operating income was $149.1 million, a 71.3% increase from the previous year, surpassing estimates [5]. - The adjusted operating income margin was 11.2%, up 390 basis points year-over-year, exceeding expectations [5]. Balance Sheet and Cash Flow - Cash and cash equivalents at the end of the quarter were $77.4 million, down from $104.2 million at the end of the previous quarter [6]. - The company utilized $108.8 million in cash from operations, with capital expenditures of $3.1 million and adjusted free cash flow of $105.8 million [6]. Fiscal 2024 Guidance - For fiscal 2024, Maximus expects revenues of $5.15-$5.25 billion, adjusted earnings of $5.65-$5.85 per share, and free cash flow between $330 million and $370 million [7]. - Interest expenses are anticipated to be $77 million [7]. Estimate Revisions - There has been an upward trend in estimates revisions over the past month, with the consensus estimate shifting by 9.68% [8][9]. Stock Outlook - Maximus holds a strong Growth Score of A and an aggregate VGM Score of A, indicating strong potential for above-average returns in the coming months [9][10].

Core Viewpoint - Maximus (MMS) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system emphasizes the importance of changing earnings estimates in determining stock price movements, particularly due to the actions of institutional investors [4][6]. - Maximus is projected to earn $5.79 per share for the fiscal year ending September 2024, reflecting a year-over-year increase of 51.2% [8]. Analyst Sentiment and Market Position - Analysts have raised their earnings estimates for Maximus, with a 7% increase in the Zacks Consensus Estimate over the past three months [8]. - The Zacks Rank system maintains a balanced distribution of ratings, with only the top 5% of stocks receiving a 'Strong Buy' rating, indicating Maximus's strong position in earnings estimate revisions [9][10].

Maximus, Inc. (MMS) stock has appreciated 9% in the past month, outperforming the S&P 500 composite's 5.9% growth. Reasons Why MMS is an Attractive Pick Now Commitment to shareholder returns makes Maximus a reliable way for investors to compound wealth over the long term. During fiscal 2023, 2022 and 2021, Maximus paid cash dividends of $68.1 million, $68.7 million and $68.8 million, respectively. Other Stocks to Consider Here are some other top-ranked stocks from the broader Business Service sector that in ...

Maximus, Inc. (MMS) reported impressive second-quarter fiscal 2024 results, with earnings and revenues surpassing the Zacks Consensus Estimate. The stock increased 2.7% since the earnings release on May 8 in response to the better-than-expected results and raised guidance for fiscal 2024. For fiscal 2024, the company expects revenues of $5.15-$5.25 billion compared with the $5.05-$5.2 billion mentioned previously. The mid-point ($5.2 billion) of the raised guidance is higher than the Zacks Consensus Estimat ...